![David M. Brand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Brand
Gründer bei
Tarsa Therapeutics, Inc.
Profil
David M.
Brand is the founder of Tarsa Therapeutics, Inc., founded in 2009, where the title held is Director.
Former jobs include President & Chief Executive Officer at CardioKine, Inc. from 2004 to 2007, Director at InteKrin Therapeutics, Inc., Director at NeurAxon, Inc., Principal at Biogen, Inc., Vice President at GlaxoSmithKline, Inc., and Principal at Cie de Recherches d'Etude et de Gestion Immobilière SA. Education includes undergraduate studies at Concordia University.
Aktive Positionen von David M. Brand
| Unternehmen | Position | Beginn |
|---|---|---|
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von David M. Brand
| Unternehmen | Position | Ende |
|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Präsident | 01.09.2007 |
Cie de Recherches d'Etude et de Gestion Immobilière SA
 Cie de Recherches d'Etude et de Gestion Immobilière SA Real Estate Investment TrustsFinance Specializes in real-estate investments | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Direktor/Vorstandsmitglied | - |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Direktor/Vorstandsmitglied | - |
Ausbildung von David M. Brand
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Cie de Recherches d'Etude et de Gestion Immobilière SA
Cie de Recherches d'Etude et de Gestion Immobilière SA Real Estate Investment TrustsFinance Specializes in real-estate investments | Finance |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Health Technology |
Wählen Sie MarketScreener 
